FONTEYNE PAUL R.
SEC CIK 1727550 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | Dir | 3,947 | $75.0K | — | 1 | 2022-01-06 | 2022-01-06 |
Most active insiders at AMLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| 2 | Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| 3 | Mazzariello Gina | CLO | — | $1.18M |
| 4 | FRATES JAMES M | CFO | — | $708.4K |
| 5 | Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| 6 | Firestone Karen | Dir | $152.2K | — |
| 7 | MILNE GEORGE M JR | Dir | — | — |
FONTEYNE PAUL R. made no open-market trades at AMLX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-10 | 2022-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | FONTEYNE PAUL R. | Dir | P - Purchase | $19.00 | +3,947 | 3,947 | New | +$75.0K |
Purchase Sale Sale after option exercise All abbreviations